Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Jan-22 12:43 PM View:  | Cdk Associates, L.L.C. 10% Owner | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition (other) | 8,060,680 | -- | -- | (100%) 8.06M to 0 | |
| 06-Oct-21 7:42 PM View: | Steineger Hilde H Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 64,258 | -- | -- | (100%) 64.26K to 0 | |
| 06-Oct-21 7:42 PM View: | Kollender Richard S President and CFO | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 234,229 | -- | -- | (100%) 234.23K to 0 | |
| 06-Oct-21 7:41 PM View: | Kong Garheng Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 63,993 | -- | -- | (100%) 63.99K to 0 | |
| 06-Oct-21 7:42 PM View: | Cohen Fredric J. Chief Medical Officer | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 160,408 | -- | -- | (50%) 320.82K to 160.41K | |
| 06-Oct-21 7:42 PM View: | Johnson John H Chief Executive Officer Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 610,092 | -- | -- | (100%) 610.09K to 0 | |
| 06-Oct-21 7:41 PM View: | Steen Marten Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 64,151 | -- | -- | (100%) 64.15K to 0 | |
| 06-Oct-21 7:40 PM View: | Long Stephen J Chief Legal Officer | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 117,793 | -- | -- | (100%) 117.79K to 0 | |
| 06-Oct-21 7:41 PM View: | Sherman Jeffrey W Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 64,258 | -- | -- | (100%) 64.26K to 0 | |
| 06-Oct-21 7:43 PM View: | Wilhoit Scott L. Chief Commercial Officer | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 109,510 | -- | -- | (100%) 109.51K to 0 | |
| 06-Oct-21 7:41 PM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 05-Oct-21 | Disposition | 78,058 | -- | -- | (100%) 78.06K to 0 | |
| 05-Oct-21 7:24 PM View: | Steineger Hilde H Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 17,763 | $2.06 | $36,591.80 | (22%) 82.02K to 64.26K | 4% |
| 05-Oct-21 7:27 PM View: | Kollender Richard S President and CFO | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 64,791 | $2.06 | $133,469.00 | (22%) 299.02K to 234.23K | 4% |
| 05-Oct-21 7:22 PM View: | Kong Garheng Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 17,763 | $2.06 | $36,591.80 | (22%) 81.76K to 63.99K | 4% |
| 05-Oct-21 7:24 PM View: | Johnson John H Chief Executive Officer Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 334,868 | $2.06 | $689,828.00 | (35%) 944.96K to 610.09K | 4% |
| 05-Oct-21 7:26 PM View: | Steen Marten Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise Duplicate | 17,763 | $2.06 | $36,591.80 | (22%) 81.91K to 64.15K | 4% |
| 05-Oct-21 7:28 PM View: | Long Stephen J Chief Legal Officer | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 49,307 | $2.06 | $101,572.00 | (30%) 167.1K to 117.79K | 4% |
| 05-Oct-21 7:28 PM View: | Wilhoit Scott L. Chief Commercial Officer | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 27,515 | $2.06 | $56,680.90 | (20%) 137.03K to 109.51K | 4% |
| 05-Oct-21 7:23 PM View: | Sherman Jeffrey W Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 17,763 | $2.06 | $36,591.80 | (22%) 82.02K to 64.26K | 4% |
| 05-Oct-21 7:21 PM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 17,763 | $2.06 | $36,591.80 | (19%) 95.82K to 78.06K | 4% |
| 05-Oct-21 7:26 PM View: | Cohen Fredric J. Chief Medical Officer | Strongbridge Biopharma Plc (SBBP) | 01-Oct-21 | Payment of Exercise | 51,548 | $2.06 | $106,189.00 | (24%) 211.96K to 160.41K | 4% |
| 08-Sep-21 4:42 PM View: | Kollender Richard S President and CFO | Strongbridge Biopharma Plc (SBBP) | 03-Sep-21 | Payment of Exercise | 17,088 | $2.24 | $38,277.10 | (5%) 316.11K to 299.02K | 12% |
| 07-Jul-21 5:01 PM View: | Johnson John H Chief Executive Officer Director | Strongbridge Biopharma Plc (SBBP) | 02-Jul-21 | Payment of Exercise | 50,867 | $3.08 | $156,670.00 | (5%) 995.83K to 944.96K | 36% |
| 18-May-21 7:14 PM View: | Steen Marten Director | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant Duplicate | 40,000 | -- | -- | 95% 41.91K to 81.91K | |
| 18-May-21 7:12 PM View: | Sherman Jeffrey W Director | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant | 40,000 | -- | -- | 95% 42.02K to 82.02K | |
| 18-May-21 7:10 PM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant | 40,000 | -- | -- | 72% 55.82K to 95.82K | |
| 18-May-21 7:15 PM View: | Steineger Hilde H Director | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant | 40,000 | -- | -- | 95% 42.02K to 82.02K | |
| 18-May-21 7:11 PM View: | Kong Garheng Director | Strongbridge Biopharma Plc (SBBP) | 18-May-21 | Grant | 40,000 | -- | -- | 96% 41.76K to 81.76K | |
| 18-May-21 7:08 PM View: | Kollender Richard S President and CFO | Strongbridge Biopharma Plc (SBBP) | 17-May-21 | Payment of Exercise | 11,392 | $2.28 | $25,973.80 | (3%) 327.5K to 316.11K | 14% |
| 18-May-21 7:06 PM View: | Steen Marten Director | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 19,004 | $2.35 | $44,659.40 | (31%) 60.92K to 41.91K | 16% |
| 17-May-21 6:31 PM View: | Sherman Jeffrey W Director | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 18,944 | $2.35 | $44,518.40 | (31%) 60.97K to 42.02K | 16% |
| 17-May-21 6:29 PM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 19,075 | $2.35 | $44,826.20 | (25%) 74.9K to 55.82K | 16% |
| 17-May-21 6:33 PM View: | Steineger Hilde H Director | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 18,944 | $2.35 | $44,518.40 | (31%) 60.97K to 42.02K | 16% |
| 17-May-21 7:27 PM View: | Kong Garheng Director | Strongbridge Biopharma Plc (SBBP) | 14-May-21 | Payment of Exercise | 19,200 | $2.35 | $45,120.00 | (31%) 60.96K to 41.76K | 16% |
| 09-Apr-21 5:13 PM View: | Johnson John H Chief Executive Officer Director | Strongbridge Biopharma Plc (SBBP) | 08-Apr-21 | Payment of Exercise | 17,325 | $2.68 | $46,431.00 | (2%) 1.01M to 995.83K | 26% |
| 05-Mar-21 4:50 PM View: | Kollender Richard S President and CFO | Strongbridge Biopharma Plc (SBBP) | 03-Mar-21 | Grant | 80,000 | -- | -- | 32% 247.5K to 327.5K | |
| 23-Feb-21 5:15 PM View: | Long Stephen J Chief Legal Officer | Strongbridge Biopharma Plc (SBBP) | 22-Feb-21 | Payment of Exercise | 7,062 | $3.62 | $25,564.40 | (4%) 174.16K to 167.1K | 46% |
| 23-Feb-21 5:16 PM View: | Wilhoit Scott L. Chief Commercial Officer | Strongbridge Biopharma Plc (SBBP) | 22-Feb-21 | Payment of Exercise | 7,121 | $3.62 | $25,778.00 | (5%) 144.15K to 137.03K | 46% |
| 23-Feb-21 5:14 PM View: | Cohen Fredric J. Chief Medical Officer | Strongbridge Biopharma Plc (SBBP) | 22-Feb-21 | Payment of Exercise | 6,978 | $3.62 | $25,260.40 | (3%) 218.93K to 211.96K | 46% |
| 23-Feb-21 5:16 PM View: | Lutz Robert Matthew Chief Financial Officer | Strongbridge Biopharma Plc (SBBP) | 22-Feb-21 | Payment of Exercise | 6,978 | $3.62 | $25,260.40 | (4%) 188.31K to 181.33K | 46% |
| 08-Jan-21 8:33 AM View: | Johnson John H Chief Executive Officer Director | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 491,000 | -- | -- | 94% 522.15K to 1.01M | |
| 08-Jan-21 8:35 AM View: | Long Stephen J Chief Legal Officer | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 143,500 | -- | -- | 468% 30.66K to 174.16K | |
| 08-Jan-21 8:35 AM View: | Lutz Robert Matthew Chief Financial Officer | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 147,500 | -- | -- | 361% 40.81K to 188.31K | |
| 08-Jan-21 8:37 AM View: | Wilhoit Scott L. Chief Commercial Officer | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 113,000 | -- | -- | 363% 31.15K to 144.15K | |
| 08-Jan-21 8:33 AM View: | Cohen Fredric J. Chief Medical Officer | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 181,000 | -- | -- | 477% 37.93K to 218.93K | |
| 08-Jan-21 8:34 AM View: | Kollender Richard S Chief Operating Officer | Strongbridge Biopharma Plc (SBBP) | 07-Jan-21 | Grant | 147,500 | -- | -- | 148% 100.0K to 247.5K | |
| 28-Sep-20 7:48 AM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 24-Sep-20 | Market Purchase | 8,000 | $2.13 | $17,040.00 | 12% 66.9K to 74.9K | (8%) |
| 21-Sep-20 9:48 PM View: | Cdk Associates, L.L.C. 10% Owner | Strongbridge Biopharma Plc (SBBP) | 18-Sep-20 | Market Purchase | 6,000 | $2.20 | $13,200.00 | < 1% 8.05M to 8.06M | (10%) |
| 21-Sep-20 9:48 PM View: | Cdk Associates, L.L.C. 10% Owner | Strongbridge Biopharma Plc (SBBP) | 17-Sep-20 | Market Purchase | 1,473,380 | $2.25 | $3,315,100.00 | 22% 6.58M to 8.05M | (12%) |
| 04-Sep-20 4:28 PM View: | Gill David N Director | Strongbridge Biopharma Plc (SBBP) | 03-Sep-20 | Payment of Exercise | 23,104 | $3.61 | $83,405.40 | (26%) 90.0K to 66.9K | 45% |
